The formulation and stability of biopharmaceutical products, especially those containing mRNA and proteins in the amorphous solid state. A fascinating but yet mysterious state of matter in which many protein drugs are stored and/or marketed.

The development and application of analytical solutions for problems associated with the manufacture and characterization of biopharmaceutical, including recombinant proteins, monoclonal antibodies, and advanced therapies

Novel, high throughput, robust technologies for the characterisation of protein glycosylation, implicated in all biological processes, and pathologies as well as in biopharmaceutical drugs’ efficacy and safety

Understanding and improving the cell systems used to create advanced therapies with an emphasis on the cellular and molecular mechanisms involved.